Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

NVO 46.41 +0.24 (0.52%)
price chart
Momentum Stocks in Focus - Novo Nordisk A/S (ADR)(NYSE:NVO), XOMA Corp ...
Novo Nordisk A/S (ADR)( NYSE:NVO) engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark.
Drug Manufacturers: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Prana ...
On 1 JULY Novo Nordisk A/S (ADR) (NYSE:NVO) initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.
Related articles »  
Notable Stocks: MEI Pharma Inc (NASDAQ:MEIP), Dr. Reddy's Laboratories ...
On June 23, Novo Nordisk A/S (ADR) (NYSE:NVO) Victoza (liraglutide 3 mg) showed statistically significant results in the randomized, placebo-controlled, double-blind, phase IIIa SCALE Diabetes study (n=846) for chronic weight management.
Related articles »  
Trader's recap: Teva Pharmaceutical Industries (NYSE:TEVA), Amarin ...
On last trading day Novo Nordisk A/S (ADR) (NYSE:NVO) ended up 0.22% higher to close at $45.53 while trading in the range of $45.13 - $45.58.
Related articles »  
Novo Nordisk A/S Rating Reiterated by Zacks (NVO)
Zacks' analyst wrote, ´┐ŻNovo Nordisk reported first-quarter 2014 earnings of $0.45 per ADR, a penny above the Zacks Consensus Estimate of $0.44.
Related articles »  
Novo Nordisk A/S Receives Neutral Rating from Zacks (NVO)
Novo Nordisk A/S logo Zacks reaffirmed their neutral rating on shares of Novo Nordisk A/S (NYSE:NVO) in a research note issued to investors on Wednesday.
MannKind Corporation (NASDAQ:MNKD) Surged 9.60%: Furiex ...
On June 25, Novo Nordisk A/S (ADR) (NYSE:NVO) is teaming up with NBA great and Hall of Famer Dominique Wilkins to launch Dominique's Diabetes Dream Team, a national initiative to help adults with type 2 diabetes customize a full-court approach to ...
Novo Nordisk A/S: Share repurchase programme
Headquartered in Denmark, Novo Nordisk employs approximately. 40,000 employees in 75 countries, and markets its products in more than 180 countries.
Related articles »